Shanghai Shenqi Pharmaceutical Investment Management Co Ltd B (900904) - Total Liabilities
Based on the latest financial reports, Shanghai Shenqi Pharmaceutical Investment Management Co Ltd B (900904) has total liabilities worth $614.48 Million USD as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore long-term investment intensity of Shanghai Shenqi Pharmaceutical Investmen to see how much of total assets are deployed in long-term investments.
Shanghai Shenqi Pharmaceutical Investment Management Co Ltd B - Total Liabilities Trend (2015–2024)
This chart illustrates how Shanghai Shenqi Pharmaceutical Investment Management Co Ltd B's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see Shanghai Shenqi Pharmaceutical Investmen assets under control.
Shanghai Shenqi Pharmaceutical Investment Management Co Ltd B Competitors by Total Liabilities
The table below lists competitors of Shanghai Shenqi Pharmaceutical Investment Management Co Ltd B ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Globe Industries Corp
TW:1324
|
Taiwan | NT$220.64 Million |
|
Hidropar Hareket Kontrol Teknolojileri Merkezi Sanayi ve Ticaret A.S.
IS:HKTM
|
Turkey | TL827.76 Million |
|
Lithium Energy Ltd
AU:LEL
|
Australia | AU$2.64 Million |
|
DC HEALTHCARE HOLDINGS BERHAD
KLSE:0283
|
Malaysia | RM71.79 Million |
|
WOLFTANK-ADISA HLDG O.N.
F:WAH
|
Germany | €90.35 Million |
|
KBC Global Limited
NSE:KBCGLOBAL
|
India | Rs1.77 Billion |
|
Otto Energy Ltd
AU:OEL
|
Australia | AU$11.15 Million |
|
West Coast Silver Ltd
AU:WCE
|
Australia | AU$1.16 Million |
Liability Composition Analysis (2015–2024)
This chart breaks down Shanghai Shenqi Pharmaceutical Investment Management Co Ltd B's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See how leveraged is Shanghai Shenqi Pharmaceutical Investmen's balance sheet to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.15 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.27 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.20 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Shanghai Shenqi Pharmaceutical Investment Management Co Ltd B's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Shanghai Shenqi Pharmaceutical Investment Management Co Ltd B (2015–2024)
The table below shows the annual total liabilities of Shanghai Shenqi Pharmaceutical Investment Management Co Ltd B from 2015 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $689.01 Million | -22.48% |
| 2023-12-31 | $888.77 Million | -12.38% |
| 2022-12-31 | $1.01 Billion | +34.09% |
| 2021-12-31 | $756.45 Million | -1.79% |
| 2020-12-31 | $770.28 Million | -13.90% |
| 2019-12-31 | $894.60 Million | +69.51% |
| 2018-12-31 | $527.74 Million | -6.65% |
| 2017-12-31 | $565.34 Million | -0.39% |
| 2016-12-31 | $567.56 Million | +47.43% |
| 2015-12-31 | $384.98 Million | -- |
About Shanghai Shenqi Pharmaceutical Investment Management Co Ltd B
Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd., together with its subsidiaries, operates as a pharmaceutical manufacturing holding investment company in China. The company engages in the research and development, and production of anti-tumor, cardiovascular, cerebrovascular, rheumatism bone pain, tonic and sedative, cold and cough, anti-fungal, gynecology, and other treatment fiel… Read more